MediWound Ltd. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
MDWD Nasdaq 2836 www.mediwound.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for MediWound Ltd.

MediWound (MDWD) Q2 2026 Earnings Call Transcript - Aug 20th, 2026 6:42 am
MediWound Ltd. Q2 2026 Earnings Call Summary - Aug 14th, 2026 6:30 am
MediWound Ltd (MDWD) (Q2 2026) Earnings Call Highlights: Record NexoBrid Sales and EscharEx ... - Aug 13th, 2026 5:07 pm
MediWound Q2 Earnings Call Highlights - Aug 13th, 2026 12:04 pm
MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates - Aug 13th, 2026 6:15 am
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update - Aug 13th, 2026 5:00 am
ProKidney Corp. (PROK) Reports Q2 Loss, Misses Revenue Estimates - Aug 10th, 2026 3:55 pm
MediWound to Report Second Quarter 2026 Financial Results - Jul 29th, 2026 6:00 am
Will MediWound (NASDAQ:MDWD) Spend Its Cash Wisely? - May 28th, 2026 6:53 am
MediWound Ltd. Q1 2026 Earnings Call Summary - May 28th, 2026 6:30 am
MediWound Ltd (MDWD) Q1 2026 Earnings Call Highlights: Strategic Collaborations and Revenue ... - May 27th, 2026 3:00 pm
MediWound (MDWD) Q1 2026 Earnings Transcript - May 27th, 2026 12:34 pm
MediWound Q1 Earnings Call Highlights - May 27th, 2026 8:06 am
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates - May 27th, 2026 6:10 am
Profound Medical (PROF) Reports Q1 Loss, Tops Revenue Estimates - May 7th, 2026 3:55 pm
MediWound to Report First Quarter 2026 Financial Results - May 7th, 2026 6:00 am
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences - Apr 7th, 2026 5:00 am